全文获取类型
收费全文 | 2564190篇 |
免费 | 213057篇 |
国内免费 | 7662篇 |
专业分类
耳鼻咽喉 | 34518篇 |
儿科学 | 84767篇 |
妇产科学 | 72210篇 |
基础医学 | 357980篇 |
口腔科学 | 74589篇 |
临床医学 | 230378篇 |
内科学 | 509243篇 |
皮肤病学 | 58491篇 |
神经病学 | 210127篇 |
特种医学 | 104358篇 |
外国民族医学 | 720篇 |
外科学 | 395384篇 |
综合类 | 63480篇 |
现状与发展 | 5篇 |
一般理论 | 915篇 |
预防医学 | 204436篇 |
眼科学 | 57243篇 |
药学 | 187570篇 |
7篇 | |
中国医学 | 4442篇 |
肿瘤学 | 134046篇 |
出版年
2018年 | 25111篇 |
2016年 | 22836篇 |
2015年 | 26069篇 |
2014年 | 36226篇 |
2013年 | 54887篇 |
2012年 | 70419篇 |
2011年 | 74966篇 |
2010年 | 45648篇 |
2009年 | 44022篇 |
2008年 | 70973篇 |
2007年 | 75274篇 |
2006年 | 76836篇 |
2005年 | 74463篇 |
2004年 | 72336篇 |
2003年 | 69705篇 |
2002年 | 67205篇 |
2001年 | 120097篇 |
2000年 | 123643篇 |
1999年 | 103750篇 |
1998年 | 28809篇 |
1997年 | 25855篇 |
1996年 | 26478篇 |
1995年 | 27707篇 |
1994年 | 26043篇 |
1993年 | 24468篇 |
1992年 | 86920篇 |
1991年 | 84796篇 |
1990年 | 82082篇 |
1989年 | 78971篇 |
1988年 | 73463篇 |
1987年 | 72357篇 |
1986年 | 68532篇 |
1985年 | 66274篇 |
1984年 | 50186篇 |
1983年 | 42734篇 |
1982年 | 25993篇 |
1981年 | 23342篇 |
1980年 | 21965篇 |
1979年 | 46838篇 |
1978年 | 33257篇 |
1977年 | 28103篇 |
1976年 | 26163篇 |
1975年 | 27587篇 |
1974年 | 33261篇 |
1973年 | 31986篇 |
1972年 | 29481篇 |
1971年 | 27565篇 |
1970年 | 25291篇 |
1969年 | 23765篇 |
1968年 | 21849篇 |
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
91.
N. Tanaka Y. Kunihiro R. Kawano T. Yujiri K. Ueda T. Gondo T. Matsumoto 《Clinical radiology》2021,76(1):50-59
92.
G.R. Iball D. Tolan G.R. Avery L.H. Cope T. Hoare H. Lambie A. Lowe R.J. de Noronha C.L. Roberts M.E. Wilkinson P. Woolfall 《Clinical radiology》2021,76(8):626.e13-626.e21
93.
94.
We describe a 3‐month‐old child with an infantile hemangioma on the forehead with a blanched macule provoked by topical treatment with propranolol. This observation demonstrates that topically applied (non‐selective) beta‐blockers may induce blanched macules at the site of application, a side effect due to peripheral vasoconstriction of blood vessels by non‐selective beta‐2 blockade. This side effect was linked due to overuse and was reversible. This case illustrates the importance of providing thorough instructions regarding topical propranolol application. 相似文献
95.
Digestive Diseases and Sciences - 相似文献
96.
97.
B.R. Mussmann S.D. Mørup P.M. Skov S. Foley A.S. Brenøe F. Eldahl G.M. Jørgensen H. Precht 《Radiography》2021,27(1):1-7
IntroductionOrgan-based tube current modulation (OBTCM) is designed for anterior dose reduction in Computed Tomography (CT). The purpose was to assess dose reduction capability in chest CT using three organ dose modulation systems at different kVp settings. Furthermore, noise, diagnostic image quality and tumour detection was assessed.MethodsA Lungman phantom was scanned with and without OBTCM at 80–135/140 kVp using three CT scanners; Canon Aquillion Prime, GE Revolution CT and Siemens Somatom Flash. Thermo-luminescent dosimeters were attached to the phantom surface and all scans were repeated five times. Image noise was measured in three ROIs at the level of the carina. Three observers visually scored the images using a fivestep scale. A Wilcoxon Signed-Rank test was used for statistical analysis of differences.ResultsUsing the GE revolution CT scanner, dose reductions between 1.10 mSv (12%) and 1.56 mSv (24%) (p < 0.01) were found in the anterior segment and no differences posteriorly and laterally. Total dose reductions between 0.64 (8%) and 0.91 mSv (13%) were found across kVp levels (p < 0.00001). Maximum noise increase with OBTCM was 0.8 HU. With the Canon system, anterior dose reductions of 6–10% and total dose reduction of 0.74–0.76 mSv across kVp levels (p < 0.001) were found with a maximum noise increase of 1.1 HU. For the Siemens system, dose increased by 22–51% anteriorly; except at 100 kVp where no dose difference was found. Noise decreased by 1 to 1.5 HU.ConclusionOrgan based tube current modulation is capable of anterior and total dose reduction with minimal loss of image quality in vendors that do not increase posterior dose.Implications for practiceThis research highlights the importance of being familiar with dose reduction technologies. 相似文献
98.
Eirini D. Basdeki Christiana Tsirimiagkou Antonios Argyris George Moschonis Petros Sfikakis Athanase D. Protogerou Kalliopi Karatzi 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(1):85-94
Background and aimsIncreased alcohol consumption has been associated with CVD risk. Subclinical arterial damage (SAD) precedes the onset of cardiovascular disease (CVD), and allows early identification and study of the pathophysiology of CVD. Reliable, noninvasive vascular biomarkers are available for the early detection of SAD and reclassification of CVD risk. To investigate the association of alcohol consumption with multiple SAD biomarkers and central hemodynamics in a large sample of Greek adults with CVD risk factors.Methods and resultsThis cross-sectional study was conducted with 938 participants (43.5% men) and collected data on SAD biomarkers, central hemodynamics, and dietary intake. Multiple linear regression analysis was performed according to sex after adjusting for several confounders. In men, alcohol consumption of 20–30 g/d was positively associated with mean, diastolic, and peripheral systolic blood pressure (BP). The consumption of >30 g/d was positively associated with the augmentation index. In women, no statistically significant associations were found between alcohol consumption and BP or SAD indices. No statistically significant associations were found between alcohol consumption and arterial compliance or distensibility in both sexes.ConclusionIn men even a small deviation from the current recommendation for alcohol consumption is associated with both higher BP indices and pressure wave reflections. The absence of association in women might be due to very low alcohol intake, even in the high consumption group. More studies are needed to verify our findings and establish the above associations in each sex. 相似文献
99.
100.
Syed S. Razi Joy A. Stephens-McDonnough Safi Haq Michael Fabbro Aliercy Nunez Sanchez Richard H. Epstein Nestor R. Villamizar Dao M. Nguyen 《The Journal of thoracic and cardiovascular surgery》2021,161(5):1689-1701
ObjectiveTo evaluate differences in postoperative pain control and opioids requirement in thoracic surgical patients following implementation of an Enhanced Recovery after Thoracic Surgery protocol with a comprehensive postoperative pain management strategy.Material and MethodsA retrospective analysis of a prospectively maintained database of patients undergoing pulmonary resections by robotic thoracoscopy or thoracotomy from January 1, 2017, to January 31, 2019, was conducted. Multimodal pain management strategy (opioid-sparing analgesics, infiltration of liposomal bupivacaine to intercostal spaces and surgical sites, and elimination of thoracic epidural analgesia use in thoracotomy patients) was implemented as part of Enhanced Recovery after Thoracic Surgery on February 1, 2018. Outcome metrics including patient-reported pain levels, in-hospital and postdischarge opioids use, postoperative complications, and length of stay were compared before and after protocol implementation.ResultsIn total, 310 robotic thoracoscopy and 62 thoracotomy patients met the inclusion criteria. This pain management strategy was associated with significant reduction of postoperative pain in both groups with an overall reduction of postoperative opioids requirement. Median in-hospital opioids use (morphine milligram equivalent per day) was reduced from 30 to 18.36 (P = .009) for the robotic thoracoscopy group and slightly increased from 15.48 to 21.0 (P = .27) in the thoracotomy group. More importantly, median postdischarge opioids prescribed (total morphine milligram equivalent) was significantly reduced from 480.0 to 150.0 (P < .001) and 887.5 to 150.0 (P < .001) for the thoracoscopy and thoracotomy groups, respectively. Similar short-term perioperative outcomes were observed in both groups before and following protocol implementation.ConclusionsImplementation of Enhanced Recovery after Thoracic Surgery allows safe elimination of epidural use, better pain control, and less postoperative opioids use, especially a drastic reduction of postdischarge opioid need, without adversely affecting outcomes. 相似文献